Maven Global Fertility Infrastructure

Diving deeper into

Maven Clinic

Company Report
Through partnerships with 475+ fertility clinics and thousands of providers, Maven can serve multinational workforces across 175 countries
Analyzed 8 sources

This reach turns Maven from a U.S. telehealth perk into a global benefits infrastructure layer for employers. The hard part is not just video visits. It is stitching together local fertility clinics, cross border reimbursement, and culturally local care so a worker in Tokyo, London, or São Paulo can use one app to find a clinic, talk to a specialist, and track wallet balances and claims in local terms. Maven says it serves 175 plus countries, ties its virtual layer to 475 plus fertility clinics, and supports 23M plus lives globally.1 2 3 4

  • Maven is asset light compared with clinic owners. It does not need to build labs in every market. Instead it contracts with local clinics and overlays navigation, provider visits, and wallet administration. That is why it can cover 175 plus countries while Kindbody, which owns clinics, pairs 27 owned sites with 400 plus partner clinics across 113 countries.2 4 5
  • For employers, the product is operationally simple. HR buys one benefit, employees open the app, get matched with fertility specialists or care advocates, receive clinic referrals based on country and preferences, and see coverage and reimbursement in one place. That is especially valuable for multinationals, because 67% of Maven’s global clients support employees outside the U.S.1 3 6
  • The network matters competitively because fertility benefits are increasingly won at the enterprise level. Maven was estimated at $268M ARR in 2024 and 17M to 17.5M covered lives, and it won Amazon away from Progyny for 2025. A broad cross border clinic network helps explain why large employers pick Maven when they want one program for global teams, not separate vendors by country.2 4 6 7

The next step is deeper control of spend and outcomes inside that network. Maven is already adding earlier diagnostics, condition specific pathways, and integrations like ŌURA based cycle insights, which pushes it from navigator toward operating system for global fertility benefits. If that continues, the advantage shifts further toward platforms that can coordinate care and payments across countries without owning the clinics themselves.6 8